SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-016288
Filing Date
2022-06-09
Accepted
2022-06-09 16:27:02
Documents
17
Period of Report
2022-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50702
2 ex10-1.htm EX-10.1 1349502
3 ex10-2.htm EX-10.2 130015
4 ex10-3.htm EX-10.3 93879
5 ex10-4.htm EX-10.4 44111
6 ex-g_001.jpg GRAPHIC 1144
  Complete submission text file 0001493152-22-016288.txt   2107651

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mslp-20220603.xsd EX-101.SCH 2968
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mslp-20220603_lab.xml EX-101.LAB 34916
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mslp-20220603_pre.xml EX-101.PRE 22795
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 221006279
SIC: 2834 Pharmaceutical Preparations